Facebook
Twitter
LinkedIn
Forward
Advances in Cancer Immunotherapy: Annual Update
This is a Hybrid Event. Registrants will be able to choose if they would like to attend in-person or virtually.
Cancer treatment has evolved significantly over the past decade from a treatment paradigm anchored on surgery, chemotherapy, and radiotherapy, to one embracing molecularly-targeted therapies disrupting tumor-specific signaling pathways, as well as new approaches to mobilize the immune system. For clinicians trying to keep current with advancing immuno-oncology principles and research, the pace of these developments has brought new challenges. Recognizing these challenges, this course will provide a comprehensive clinical review of the advances taking place in the immuno-oncology field.
Target Audience
This activity is intended for physicians, nurses, physician assistants, and other members of the healthcare team.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate cancer immunotherapy principles and strategies and how they influence current treatment approaches.
- Identify the emerging role of personalized cancer vaccination and other immunotherapy combinations in patients with solid tumor and hematologic malignancies.
- Define currently approved and emerging predictive biomarkers for cancer immunotherapy.
- Recognize and implement management strategies for immune-mediated side effects in patients treated with immunotherapy agents.
- Recognize the importance of establishing a multidisciplinary approach in the immunotherapy era.
Additional Information
Massachusetts General Hospital Cancer Center & Mass General Brigham
Monday, May 1, 2023 | 7:30am - 4:30pm
7:30 am | Registration and Breakfast |
8:00 | Welcome Remarks |
8:05 | Primer | Howard L. Kaufman, MD |
8:35 | Q&A |
8:45 | Overview of Immunology Tolerance | Arlene Sharpe, MD, PhD |
9:15 | Q&A |
9:25 | Cancer Immunotherapy: Where are We Now? | Justin Gainor, MD |
9:55 | Q&A |
| 10:05 | BREAK |
10:20 | Cellular Therapies Lecture | Jeremy Abramson, MD |
10:50 | Q&A |
11:00 | Normalizing the Tumor Microenvironment to Improve Cancer Immunotherapy: Bench to Bedside | Rakesh Jain, PhD |
11:30 | Q&A |
| 11:40 | RAPID FIRE!!! Cancer Immunotherapy for the Non-Medical Oncologist
|
12:25pm | LUNCH |
1:25 | Palliative Care | Laura Petrillo, MD |
1:50 | Q&A |
2:05 | Mechanisms of Immunotherapy Toxicity | Alexandra-Chloe Villani, PhD |
2:45 | Q&A |
2:55 | Toxicity – Clinical (and Practical) | Krista Rubin, MS, FNP-BC and Riley Fadden, MSN, RN, FNP-C |
3:20 | Q&A |
3:30 | Case Studies (w/ ARS) | TBD |
4:15 | Closing Remarks |
| 4:30 pm | Adjourn |
Tuesday, May 2, 2023 | 7:30am - 1:00pm
7:30 am | Registration and Breakfast |
8:00 | Welcome Remarks |
8:05 | Resistance Biomarkers | Nir Hacohen, PhD |
| 8:35 | Q&A |
8:45 | Biomarkers Debate: Pragmatic vs. Perfect | |
9:15 | Q&A |
9:25 | Incorporating Biomarker Analysis into Optimal Treatment Selection | TBD |
9:55 | Q&A |
10:05 | Navigating Clinical Trial Data to Help Make Right Choice for Your Patient | |
| 10:35 | Q&A |
10:45 | BREAK |
11:05 | Multidisciplinary Panel Discussion | Speakers TBD |
11:35 | Q&A |
11:45 | RAPID FIRE!!! What’s Next in Immunotherapy? |
12:15 pm | Q&A |
12:25 | Wrap-Up Session
|
1:00 pm | Adjourn |
Accommodations:
A limited number of rooms have been reserved at The Westin Copley Place for the nights of April 30 and May 1 at nightly rate of $279. Hotel room rates are subject to applicable state and local taxes in effect at the time of check-out. To book your room, contact the hotel at (617) 262-9600. The reservation deadline is Friday, April 7, 2023.
Course Directors
Justin Gainor, MD
Director, Center for Thoracic Cancers,
Director of Targeted Immunotherapy,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine, Harvard Medical School
Krista Rubin, MS, FNP-BC
Nurse Practitioner, Center for Melanoma,
Massachusetts General Hospital Cancer Center
Ryan Sullivan, MD
Physician Investigator, Cancer Center, Mass General Research Institute;
Assistant In Medicine, Hematology-Oncology, Massachusetts General Hospital;
Associate Professor of Medicine, Harvard Medical School
Faculty
Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine, Harvard Medical School
Riley Fadden, MSN, RN, FNP-C
Nurse Practitioner, Center for Melanoma,
Massachusetts General Hospital Cancer Center
Florian Fintelmann, MD
Radiologist, Thoracic Imaging and Intervention,
Head, Thoracic Imaging Percutaneous Thermal Ablation,
Massachusetts General Hospital;
Associate Professor, Harvard Medical School
Ruth Foreman, MD
Assistant Pathologist, Dermatopathology Service,
Massachusetts General Hospital;
Instructor, Harvard Medical School
Nir Hacohen, PhD
Director, Center for Cancer Immunology,
Investigator, Cancer Center, Mass General Research Institute,
Massachusetts General Hospital;
Professor of Medicine, Harvard Medical School
Rakesh Jain, PhD
Director, Steele Laboratory, Massachusetts General Hospital;
A. Werk Cook Professor of Radiation Oncology, Harvard Medical School
Howard Kaufman, MD
Assistant in Surgery, Surgery, Massachusetts General Hospital;
Lecturer in Surgery, Harvard Medical School
Meghan Mooradian, MD
Clinical Oncologist, Medical Oncology, Massachusetts General Hospital;
Instructor, Harvard Medical School
Laura Petrillo, MD
Palliative Care Physician, Massachusetts General Hospital;
Assistant Professor of Medicine, Harvard Medical School
Arlene Sharpe, MD, PhD
Kolokotrones University Professor,
Chair, Department of Immunology,
Harvard Medical School
Alexandra-Chloe Villani, PhD
Director, Single-Cell Genomics Program,
Center for Immunology and Inflammatory Diseases,
Massachusetts General Hospital;
Assistant Professor of Medicine, Harvard Medical School;
Associate Scientist, Broad Institute of MIT and Harvard
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 10.25 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity
Available Credit
- 10.25 AMA PRA Category 1 Credit™
- 10.25 Nursing Contact Hours
- 10.25 Participation
Price
| Registration Type | Tuition Fee |
|---|---|
| Physician: In-Person | $159.00 |
| Physician: Virtual | $89.00 |
| Fellows/Nurses/PAs/etc.: In-Person | $109.00 |
| Fellows/Nurses/PAs/etc.: Virtual | $39.00 |
| Industry: In-Person | $399.00 |
| Industry: Virtual | $299.00 |
Cancellation Policy:
Registrations cancelled on or before April 17, 2023 will be refunded, less a $25 administrative fee. Registrations cancelled after April 17, 2023 will not be refunded.
Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.
Accommodations:
A limited number of rooms have been reserved at The Westin Copley Place for the nights of April 30 and May 1 at nightly rate of $279. Hotel room rates are subject to applicable state and local taxes in effect at the time of check-out. To book your room, contact the hotel at (617) 262-9600. The reservation deadline is Friday, April 7, 2023.